16-18869926-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_015092.5(SMG1):c.2561G>A(p.Ser854Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000155 in 1,530,566 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000099 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00016 ( 0 hom. )
Consequence
SMG1
NM_015092.5 missense
NM_015092.5 missense
Scores
2
4
12
Clinical Significance
Conservation
PhyloP100: 7.66
Genes affected
SMG1 (HGNC:30045): (SMG1 nonsense mediated mRNA decay associated PI3K related kinase) This gene encodes a protein involved in nonsense-mediated mRNA decay (NMD) as part of the mRNA surveillance complex. The protein has kinase activity and is thought to function in NMD by phosphorylating the regulator of nonsense transcripts 1 protein. Alternatively spliced transcript variants have been described, but their full-length nature has yet to be determined. [provided by RefSeq, Mar 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.20452675).
BS2
High AC in GnomAd4 at 15 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMG1 | NM_015092.5 | c.2561G>A | p.Ser854Asn | missense_variant | 19/63 | ENST00000446231.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMG1 | ENST00000446231.7 | c.2561G>A | p.Ser854Asn | missense_variant | 19/63 | 1 | NM_015092.5 | P1 | |
SMG1 | ENST00000565324.5 | c.2231G>A | p.Ser744Asn | missense_variant | 17/61 | 1 | |||
SMG1 | ENST00000563235.5 | c.854G>A | p.Ser285Asn | missense_variant | 7/17 | 2 | |||
SMG1 | ENST00000568038.1 | c.599G>A | p.Ser200Asn | missense_variant, NMD_transcript_variant | 6/10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152104Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
15
AN:
152104
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000103 AC: 21AN: 203668Hom.: 0 AF XY: 0.000109 AC XY: 12AN XY: 110316
GnomAD3 exomes
AF:
AC:
21
AN:
203668
Hom.:
AF XY:
AC XY:
12
AN XY:
110316
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000162 AC: 223AN: 1378462Hom.: 0 Cov.: 21 AF XY: 0.000165 AC XY: 114AN XY: 688924
GnomAD4 exome
AF:
AC:
223
AN:
1378462
Hom.:
Cov.:
21
AF XY:
AC XY:
114
AN XY:
688924
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74296
GnomAD4 genome
AF:
AC:
15
AN:
152104
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
74296
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
8
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2021 | The c.2561G>A (p.S854N) alteration is located in exon 19 (coding exon 19) of the SMG1 gene. This alteration results from a G to A substitution at nucleotide position 2561, causing the serine (S) at amino acid position 854 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Benign
T;.
Polyphen
D;.
Vest4
MutPred
Loss of disorder (P = 0.0964);.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at